Gynecologic Health A Novel Laser Therapy

MLTU-PPPT-A-R2

Become Yourself Again

Gynecologic Health A Novel Laser Therapy

MLTU-PPPT-A-R2

• “It” refers to changes in gynecologic health and it happens to a majority of women.

• As many as 50% of 64 million women are suffering from changes in their gynecologic health 1,2,3

MLTU-PPPT-A-R2

• Gentle fractional CO2 laser therapy

• Clinically proven to bring lasting relief

• Thousands of women successfully treated since 2012

• Overwhelmingly positive and immediate results

Because now you can do something about it.

MLTU-PPPT-A-R2

The reason for talking about the MonaLisa Touch.

Minimal side effects No downtime Lasting results

MLTU-PPPT-A-R2

Simple and Safe The MonaLisa Touch difference matters.

3 treatments of less than 5 minutes each

In-office procedure

Requires no anesthesia

Thousands of women successfully treated since 2012

MLTU-PPPT-A-R2

2 out of 4 Postmenopausal

Women are suffering from changes in their gynecologic health.

But they don’t have to.

1,2,3

as many as

MLTU-PPPT-A-R2

Clinically Proven to bring lasting relief.

A study was done by Dr. Stefano Salvatore*, Department of Obstetrics and Gynecology, Vita- Salute San Raffaele University to assess the feasibility of fractional C02 laser in the treatment of 50 women suffering changes in their gynecologic health. • Overwhelmingly positive and immediate results

• Highly statistically significant improvement in symptoms after first treatment

• 42 patients (84%) showed significant improvement in their physical and mental quality of life scores over baseline and were satisfied with the treatment. Gynecologic symptoms were significantly improved.

SOURCE: Study done in conjunction with doctors: R.E. Nappi, N. Zerbinati, A.Calligaro, S. Ferrero, M. Origoni, M. Candiani, U. Leone

Roberti MaggioreMLTU-PPPT-A-R2

Simple and Safe The MonaLisa Touch difference matters.

Virtually

MLTU-PPPT-A-R2

It’s OK to talk about it and become yourself again.

SOURCES 1 US Census, 2010 2 The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20(9):888-902 3 Gass ML, Cochrane BB, Larson JC, et al. Patterns and predictors of sexual health activity among women in the hormone therapy trials of the Women’s Health Initiative. Menopause. 2011:18(11):1160-1171

MLTU-PPPT-A-R2